ONCOPEPTIDES
Oncopeptides is a clinical stage company backed by HealthCap and Industrifonden that has raised approximately 16.5 MEUR in Early Stage and Series A financing to 2015. Oncopeptides lead compound, named melflufen, is a peptidase potentiated therapy within oncology. Melflufen is a very potent anti-angiogenetic compound, triggers rapid, robust, and irreversible DNA damage and exerts it cytotoxicity through alkylation of DNA. Melflufen is currently undergoing Phase 2 efficacy studies in patients with relapsed and relapsed-refractory multiple myeloma. The peptidase targeting causes melflufen and its metabolites to accumulate in the diseased cells. This results in targeted delivery of the active moieties to the cancer cells, and thereby better treatment of the disease.
ONCOPEPTIDES
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
2000-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.oncopeptides.com
Total Employee:
251+
Status:
Active
Contact:
46 7 05 69 54 71
Email Addresses:
[email protected]
Total Funding:
209.18 M USD
Technology used in webpage:
Domain Not Resolving Global Site Tag IPv6 US Privacy User Signal Mechanism DoubleClick.Net Cloudflare SSL Amazon Virginia Region Cloudflare CDN ASP.NET 4.0 ASP.NET Ajax
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Vinnova
Vinnova investment in Grant - Oncopeptides
Artisan Partners
Artisan Partners investment in Post-IPO Equity - Oncopeptides
Bain Capital
Bain Capital investment in Post-IPO Equity - Oncopeptides
Industrifonden
Industrifonden investment in Series A - Oncopeptides
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-01 | Oncopeptides appoints Annika Muskantor as interim CFO |
Official Site Inspections
http://www.oncopeptides.com Semrush global rank: 437.71 K Semrush visits lastest month: 121.55 K
Unable to get host informations!!!
